Why Most Healthcare Agencies Are Blind to Competitor Intelligence — And Why ICG Isn't

What "monitoring competitors" usually means at agencies

Pull aside an agency account manager and ask "how do you monitor competitors?" The honest answer:

• "We check their websites occasionally."
• "We scan Meta Ad Library when something changes."
• "We watch their social media presence."
• "We have a Google Doc tracker."

All of these are real activities. None are systematic competitive intelligence. They're "occasional awareness" presented as continuous oversight.

What systematic competitor intelligence requires

1. Daily automated tracking across 30-75 brands per specialty cluster
2. Spend estimation from publicly observable ad data
3. Run-length archive with historical depth
4. Hook + offer pattern analysis across the cluster
5. Emergence signal detection (offers appearing across 3+ brands trigger alerts)
6. Cross-platform integration (Meta + Google + landing page pricing)
7. Healthcare-specialty calibration (NMC + ABDM + ART Act + DPDP compliance signals)
8. Client-accessible workspace (clients see the same intelligence the agency does)

Building this is engineering work. ~6-12 months of dedicated development for healthcare-specific tooling.

Why most agencies don't build it

Reason 1: Agencies aren't engineering organisations

Most healthcare marketing agencies are content production + creative + media buying teams. Engineering isn't core competency. Building Prism Spy-equivalent infrastructure is outside their org chart.

Reason 2: Clients don't see it as a deliverable

Agencies optimise for visible deliverables (campaigns, content, reports). Competitor intelligence is invisible work — runs in the background. Clients don't ask for it explicitly so agencies don't market it explicitly.

Reason 3: Horizontal tools are inadequate

Tools like AdScout, SocialPeta, SimilarWeb exist for general industries. None are healthcare-specific. Using them produces shallow surface-level competitor data without the healthcare context that makes it actionable.

Reason 4: It's a moat that incentivises non-building

If most agencies don't have systematic competitive intelligence, none can be punished for not having it. The market norm is shallow — clients don't know to ask for depth.

Why ICG built Prism Spy

Three reasons specific to healthcare:

1. Healthcare's competitive intensity is rising fast. The brands that don't see competitor moves coming pay 30-50% more for the same patient acquisition.
2. Healthcare-specific signals matter. NMC compliance flags, DPDP awareness on before-after, ART Act on IVF claims — generic competitor tools miss these.
3. Patient research cycles need pre-emption. Patient considering IVF for 4-6 weeks gets exposed to multiple brands. The clinic that anticipates competitor moves wins the consideration share.

What ICG clients see that other clinics don't

• Top 10 spender rankings for their specialty, refreshed daily
• Hook landscape with their brand's position mapped
• Offer evolution timeline — what offers appeared, when, where
• Emerging brand alerts 12 weeks before challengers cross ₹1Cr threshold
• Geographic strategy maps — where competitors are investing vs harvesting
• Activity Feed — every spend, hook, offer change logged with timestamp
• Run-length archives — what worked for competitors, what failed

The agency selection question

If you're a healthcare brand evaluating agencies, three questions to ask:

1. "Show me your competitor intelligence infrastructure." If they show a Google Doc or a Meta Ad Library tab, they're at the surface.
2. "What does my specialty's competitor brief look like?" If they can't produce it on demand, they don't have systematic infrastructure.
3. "How do I access the competitor intelligence?" If clients can't log in, the intelligence isn't institutional — it's agency-side anecdote.